Universal plasma from antibodies-depleted blood
CA 2645398 A1 · Owner: Ncsrt, Inc. · Inventors: Kopf, Henry
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a method of manufacturing universal plasma from blood containing serological Group A and/or Group B antibodies. The method involves contacting the blood containing serological Group A and/or Group B antibodies with a chromatography resin comprising corresponding Group A and/or Group B antigen, and recovering an antibodies-depleted blood product as the universal plasma.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.